Knight Therapeutics | GUD - Trade Debtors


Knight Therapeutics reported CAD183M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Acasti Pharma USD 20K 0 Sep/2025
Akebia Therapeutics USD 47.03M 19.19M Dec/2025
Alaunos Therapeutics USD 2K 0 Jun/2025
Aurora Cannabis CAD 44.58M 3.68M Mar/2026
Avita Medical AUD 9.11M 2.26M Dec/2025
Canopy Growth CAD 36.29M 104.13M Mar/2026
Cronos Group USD 73.17M 4.87M Mar/2026
Dianthus Therapeutics USD 1.23M 1.18M Mar/2026
Ionis Pharmaceuticals USD 74M 8M Mar/2026
IQVIA Holdings USD 3.38B 52M Mar/2026
Knight Therapeutics CAD 183M 7.46M Dec/2025
Moderna USD 71M 113M Mar/2026
Omeros USD 8.08M 440K Jun/2024
Organigram Holdings CAD 53.39M 3.45M Mar/2026
Organon & Co USD 1.38B 53M Mar/2026
Revvity USD 691.38M 53.29M Mar/2026
Tectonic Therapeutic USD 0 270K Dec/2023
Tilray USD 109.07M 2M Sep/2025
Viatris USD 3.08B 45M Mar/2026
Xeris Pharmaceuticals USD 56.29M 5.24M Mar/2026